<VariationArchive VariationID="1725967" VariationName="NM_000124.4(ERCC6):c.1040del (p.Gly347fs)" VariationType="Deletion" Accession="VCV001725967" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-11-19" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1783494" VariationID="1725967">
      <GeneList>
        <Gene Symbol="ERCC6" FullName="ERCC excision repair 6, chromatin remodeling factor" GeneID="2074" HGNC_ID="HGNC:3438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49434881" stop="49539538" display_start="49434881" display_stop="49539538" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50664490" stop="50747146" display_start="50664490" display_stop="50747146" Strand="-" />
          </Location>
          <OMIM>609413</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000124.4(ERCC6):c.1040del (p.Gly347fs)</Name>
      <CanonicalSPDI>NC_000010.11:49524389:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="49524390" stop="49524390" display_start="49524390" display_stop="49524390" variantLength="1" positionVCF="49524389" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="50732436" stop="50732436" display_start="50732436" display_stop="50732436" variantLength="1" positionVCF="50732435" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G347fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.50732438del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.50732438del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.49524392del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.49524392del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009442.1" sequenceAccession="NG_009442" sequenceVersion="1" change="g.19712del">
            <Expression>NG_009442.1:g.19712del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033155.1" sequenceAccession="NG_033155" sequenceVersion="1" change="g.4892del">
            <Expression>NG_033155.1:g.4892del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000124.4" sequenceAccession="NM_000124" sequenceVersion="4" change="c.1040del" MANESelect="true">
            <Expression>NM_000124.4:c.1040del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000115.1" sequenceAccession="NP_000115" sequenceVersion="1" change="p.Gly347fs">
            <Expression>NP_000115.1:p.Gly347fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001277058.2" sequenceAccession="NM_001277058" sequenceVersion="2" change="c.1040del" MANEPlusClinical="true">
            <Expression>NM_001277058.2:c.1040del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263987.1" sequenceAccession="NP_001263987" sequenceVersion="1" change="p.Gly347fs">
            <Expression>NP_001263987.1:p.Gly347fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001277059.2" sequenceAccession="NM_001277059" sequenceVersion="2" change="c.1040del">
            <Expression>NM_001277059.2:c.1040del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263988.1" sequenceAccession="NP_001263988" sequenceVersion="1" change="p.Gly347fs">
            <Expression>NP_001263988.1:p.Gly347fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346440.2" sequenceAccession="NM_001346440" sequenceVersion="2" change="c.1040del">
            <Expression>NM_001346440.2:c.1040del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333369.1" sequenceAccession="NP_001333369" sequenceVersion="1" change="p.Gly347fs">
            <Expression>NP_001333369.1:p.Gly347fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_465" sequenceAccession="LRG_465">
            <Expression>LRG_465:g.19712del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_465t1" sequenceAccession="LRG_465t1">
            <Expression>LRG_465t1:c.1038del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_465p1" sequenceAccession="LRG_465p1" change="p.Gly347Aspfs">
            <Expression>LRG_465p1:p.Gly347Aspfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000124.4(ERCC6):c.1040del (p.Gly347fs) AND Cockayne syndrome type 2" Accession="RCV002306938" Version="2">
        <ClassifiedConditionList TraitSetID="433">
          <ClassifiedCondition DB="MedGen" ID="C0751038">Cockayne syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-26" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000124.4(ERCC6):c.1040del (p.Gly347fs) AND not provided" Accession="RCV003099159" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-19" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-11-19" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18628313</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29572252</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="433" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1524" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 2</ElementValue>
                <XRef ID="MONDO:0019570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome B</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CSB</ElementValue>
                <XRef Type="MIM" ID="133540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1420" />
                <XRef ID="1420" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90322" DB="Orphanet" />
              <XRef ID="C0751038" DB="MedGen" />
              <XRef ID="MONDO:0019570" DB="MONDO" />
              <XRef Type="MIM" ID="133540" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5085262" SubmissionDate="2022-11-17" DateLastUpdated="2022-12-24" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="13096904|OMIM:133540" />
        <ClinVarAccession Accession="SCV002604034" DateUpdated="2022-12-24" DateCreated="2022-11-19" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>NM_000124.2(ERCC6):c.1040delG(G347Dfs*13) is expected to be pathogenic in the context of ERCC6-related disorders. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in ERCC6, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wpe7ty9o/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2021_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="T" referenceAllele="TC" start="50732435" stop="50732436" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">13096904</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="133540" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12292560</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6167717" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="6778086|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003478957" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18628313</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29572252</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly347Aspfs*13) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ERCC6-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.50732436del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5085262" TraitType="Disease" MappingType="XRef" MappingValue="133540" MappingRef="OMIM">
        <MedGen CUI="C0751038" Name="Cockayne syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6167717" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

